As of April 2024, 55 percent of the LGBT population lived in the 50 states and the District of Columbia where private health insurance service providers weren't allowed to deny coverage for transgender-related health care services, such as sex reassignment surgery. However, only 40 percent lived in states where health insurance protections included sexual orientation and gender identity.

LGBT Americans The share of Americans self-identifying as lesbian, gay, bisexual or transgender has grown in recent years. This suggests that insurance protections which cover LGBT-related health care services will also continue to grow in importance. The prevalence of younger Americans self-identifying as LGBT when compared with older generations confirms this. Millennials and Gen Xers are much more likely to personally identify as LGBT than previous generations were. Growing acceptance and tolerance in wider society means that more people are willing to be open about their gender identity and sexual orientation. For instance, support for same-sex marriage in the U.S. underwent a huge shift over the past two decades with the majority of Americans being in favor of it since 2011.

A survey conducted in 2021 found that around **** percent of people assigned male at birth still identify as male, while *** percent identified as female, and *** percent identified as transgender.

The US gender reassignment surgery market is experiencing robust growth, driven by increasing societal acceptance of transgender individuals, advancements in surgical techniques resulting in improved outcomes and patient satisfaction, and expanding access to healthcare coverage for gender-affirming care. The market's Compound Annual Growth Rate (CAGR) of 12.50% from 2019-2024 suggests a significant expansion, indicating a substantial and growing demand for these procedures. This growth is fueled by a rising transgender population seeking medical transition, coupled with increased awareness and advocacy efforts promoting access to gender-affirming surgeries. The market segmentation reveals a substantial portion dedicated to male-to-female (MTF) surgeries, encompassing procedures like feminizing vaginoplasty, augmentation mammoplasty, and facial feminization. Female-to-male (FTM) surgeries, including phalloplasty and hysterectomy, also contribute significantly, though potentially with a slightly smaller market share. The primary end-users are hospitals and specialized clinics equipped to handle the complex nature of these procedures, reflecting the need for experienced surgeons and advanced medical facilities. While precise market figures for the US are unavailable in the provided data, based on the global CAGR and considering the significant US healthcare market, a reasonable estimate for the 2025 US market size could be in the range of $500 million to $750 million, assuming a proportionally larger US market share compared to other regions. The key players in the US market comprise a mix of specialized transgender healthcare centers and established cosmetic surgery practices. This competitive landscape drives innovation and improvements in surgical techniques, further stimulating market growth. However, factors such as high procedure costs, limited insurance coverage in certain areas, and the potential for lengthy wait times due to high demand could act as restraints. Future growth will depend on continued progress in surgical techniques, expanded insurance coverage, legislative changes increasing access to care, and ongoing efforts to destigmatize gender transition. Geographic variations in access to care and societal acceptance will also influence the growth trajectory across different regions within the US. The forecast period of 2025-2033 promises a substantial expansion, projecting a larger market size in 2033 due to the continued influence of the factors mentioned above, further solidifying the position of gender reassignment surgery as a significant segment within the broader healthcare landscape. Recent developments include: April 2023: Governor Murphy signed Executive Order No. 326 establishing New Jersey as a safe haven for gender-affirming health care by directing all state departments and agencies to protect all persons, including health care professionals and patients, against potential repercussions resulting from providing and receiving assisting in providing or receiving, seeking, or traveling to New Jersey to obtain gender-affirming health care services., September 2022: The World Professional Association for Transgender Health (WPATH), headquartered in the United States, updated its Standards of Care and Ethical Guidelines for health professionals. Among the updates is a new suggestion to lift the age restriction for youth seeking gender-affirming surgical treatment, in comparison to the previous suggestion of surgery at 17 or older.. Key drivers for this market are: Growing Burden of Gender Dysphoria, Rising Government Initiatives and Reimbursements. Potential restraints include: Growing Burden of Gender Dysphoria, Rising Government Initiatives and Reimbursements. Notable trends are: Facial Feminization Procedures Segment is Expected to Have Significant Growth in the Market Over the Forecast Period.

In a global survey conducted in 2023, ***** percent of respondents from 30 countries identified themselves as transgender, non-binary/non-conforming/gender-fluid, or in another way. In Switzerland, around *** percent of the respondents stated to identify themselves with one of the listed genders.

Supplementary file 1: Data for serum/plasma laboratory tests with sex-specific reference intervals performed on patients with sexual orientation/gender identity (SOGI) field differences for legal sex/sex assigned at birth (SAAB)/gender identity (GI) in the electronic medical record (EMR) at the University of Iowa Hospitals and Clinics from January 1, 2021 to December 31, 2021. The data elements include: deidentified patient number, age (years) at time of laboratory testing, location type (outpatient, inpatient, or emergency department) at time of specimen collection, legal sex in EMR, SAAB in EMR, GI in EMR, presence of SOGI mismatch (yes/no), change of legal sex in EMR, gender-affirming gonadectomy (yes/no), GI from chart review, gender-affirming hormone and route of administration, values for tests for 17 laboratory tests, and how the values of these 17 laboratory tests were relative to age-matched reference intervals for cisgender men and women. Assays details and reference intervals are summarized in Supplemental file 3. Chart review for SOGI fields previously reported [1]. There are a total of 1,166 unique patients (all 18.0 years or older) and 7,530 laboratory tests.

Supplementary file 2: Data for plasma creatinine performed for patients 18.0 years or older taking gender-affirming estradiol or testosterone at the University of Iowa Hospitals and Clinics from January 1, 2021 to December 31, 2021. The data elements include: deidentified patient number, age (years) at time of laboratory testing, location type at time of specimen collection, legal sex in EMR, SAAB in EMR, GI in EMR, GI from chart review, gender-affirming hormone and route of administration, self-declared race in EMR (African-American or not), plasma creatinine (mg/dL), estimated glomerular filtration rate (eGFR) calculation using female sex and the 2021 CKD-EPI equation without race refit, eGFR using male as sex, and chronic kidney disease (CKD) stage using either female or male as sex. eGFR equation and CKD stages are from references 2 and 3, respectively. There are a total of 620 unique patients and 1,469 plasma creatinine values.

Supplementary file 3: Includes Supplemental Table 1 with details on laboratory assay and Supplemental Table 2 with reference intervals for the laboratory tests analyzed.

Data tabs for Supplemental Files 1 and 2 include one for primary data and another defining abbreviations.

[1] N.G. Hines et al, Patterns of gender identity data within electronic health record databases can be used as a tool for identifying and estimating the prevalence of gender-expansive people, JAMIA Open 6 (2) (2023) ooad042. DOI: 10.1093/jamiaopen/ooad042.

[2] C. Delgado et al., A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease, Am J Kidney Dis 79 (2) (2022) 268-288 e261. DOI: 10.1053/j.ajkd.2021.08.003.

[3] Kidney Int Suppl (2011) 3 (1) (2013) 5-14.

IntroductionThe Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) created separate growth charts for girls and boys because growth patterns and rates differ between sexes. However, scenarios exist in which this dichotomizing “girls versus boys” approach may not be ideal, including the care of non-binary youth or transgender youth undergoing transitions consistent with their gender identity. There is therefore a need for growth charts that age smooth differences in pubertal timing between sexes to determine how youth are growing as “children” versus “girls or boys” (e.g., age- and sex-neutral, compared to age- and sex-specific, growth charts).MethodsEmploying similar statistical techniques and datasets used to create the CDC 2000 growth charts, we developed age-adjusted, sex non-specific growth charts for height, weight, and body mass index (BMI), and z-score calculators for these parameters. Specifically, these were created using anthropometric data from five US cross-sectional studies including National Health Examination Surveys II-III and National Health and Nutrition Examination Surveys I-III. To illustrate contemporary clinical practice, we overlaid our charts on CDC 2000 girls and boys growth charts.Results39,119 youth 2-20 years old (49.5% female; 66.7% non-Hispanic White; 21.7% non-Hispanic Black) were included in the development of our growth charts, reference ranges, and z-score calculators. Respective curves were largely superimposable through around 10 years of age after which, coinciding with pubertal onset timing, differences became more apparent.DiscussionWe conclude that age-adjusted, sex non-specific growth charts may be used in clinical situations such as transgender youth in which standard “girls versus boys” growth charts are not ideal. Until longitudinal auxological data are available in these populations, our growth charts may help to assess a transgender youth’s growth trajectory and weight classification, and expectations surrounding these.

In 2023, 7.6 percent of adults surveyed in the United States stated they identify as lesbian, gay, bisexual, or transgender (LGBT). This is an increase from 2012, when 3.5 percent of surveyed adults identified as LGBT. These four categories are among the most common sexual orientations and gender identities outside cis-heterosexuals.

Differences across ages and genders 

Zooming in, it is possible to see how the share of people identifying as LGBT changed considerably according to different demographics. Only two percent of Baby Boomers, indeed, reported being part of the LGBT community. On the other hand, among Generation Z individuals, this share reached almost 16 percent. Moreover, surveys suggest that women were more likely to identify as LGBT than men.

An ever-understanding society 

The fact that an increasing amount of people feel free and safe to openly identify as LGBT might be a consequence of the improved acceptance of the different sexual orientations and genders by the American people at large. While in 2001 more than half of U.S. citizens considered homosexual relationships to be morally wrong, 20 years later this percentage dropped to 30 percent. Support for same-sex marriage has also been consistently increasing, even among traditionally conservative political groups. Despite this, it is important to remember that every year hundreds of people are still victims of hate crimes in the United States simply because of their gender or sexual orientation.

Germany and the Netherlands are the two countries in Europe with the greatest share of transgender people indicating that they have changed or are in the process of changing their legal gender, with 39 percent of respondents in both countries. Changing their gender on legal documents can be a huge milestone for many trans people, as it makes it easier for them to be identified identified according to their gender identity.

Trans people may experience great difficulties when going through the process of changing their legal gender, as many countries require medical and psychological evaluations before proceeding with the process. In such cases, where trans people do not trust public authorities to treat them in a non-discriminatory manner, very few transgender people go through the process to legally change gender, such as in Bulgaria, Lithuania, and Croatia, where less than five percent of respondents indicate they have done or are doing so.

Snapshot img

Gender Reassignment Surgery Market Size 2025-2029

The gender reassignment surgery market size is forecast to increase by USD 374.2 million, at a CAGR of 11.2% between 2024 and 2029.

The market is experiencing significant growth due to the increasing number of individuals opting for sex change procedures worldwide. This trend is driven by the growing acceptance and recognition of transgender and gender non-conforming individuals, leading to a surge in demand for medical solutions to help them align their physical identity with their gender identity. Advancements in medical technology have also played a crucial role in the market's expansion, enabling surgeons to perform these procedures more safely and effectively than ever before. However, the high cost of gender reassignment surgeries remains a significant challenge for many individuals seeking these procedures. Despite this obstacle, the market's potential for growth is substantial, particularly as societal attitudes towards gender identity continue to evolve and more individuals feel empowered to seek out the medical solutions they need to live authentically. Companies operating in this market can capitalize on this trend by offering affordable financing options, partnering with insurance providers, and investing in research and development to further advance surgical techniques and reduce costs.

What will be the Size of the Gender Reassignment Surgery Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free SampleThe market continues to evolve, driven by advancements in medical technology, growing societal acceptance, and increasing demand for comprehensive care. Surgical implants, preoperative counseling, and surgical techniques are constantly improving to enhance patient satisfaction and outcomes. Body image, a significant factor in the decision-making process, is addressed through various means, including social support groups and mental health services. Gender identity, a complex construct, is being explored through clinical trials and psychological counseling, aiming to provide more personalized and effective care. Hormone therapy, a crucial aspect of gender affirmation, is subject to ongoing research and refinement. Healthcare costs, a barrier for many, are being addressed through insurance coverage and medical tourism. Infection control, surgical risks, and pain management are essential components of quality care, with data analysis and evidence-based practices guiding best practices. Facial feminization and breast augmentation are popular procedures, but genital reconstruction and voice therapy are also gaining attention. Ethical considerations, patient advocacy, and long-term effects are crucial areas of focus. Sexual health, scar management, fertility preservation, and postoperative support are essential aspects of holistic care. Professional guidelines and post-operative care ensure consistent quality, while follow-up appointments and community resources provide ongoing support. Psychosocial assessment and informed consent forms are integral parts of the preoperative process. Medical imaging and patient education are essential for accurate diagnosis and effective treatment. The market is characterized by continuous dynamism, with ongoing unfolding of market activities and evolving patterns. Adverse events, healthcare access, and patient advocacy are ongoing concerns, requiring constant attention and innovation. The ultimate goal is to improve patient outcomes, enhance quality of life, and ensure ethical and compassionate care.

How is this Gender Reassignment Surgery Industry segmented?

The gender reassignment surgery industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. TypeMale to femaleFemale to maleEnd-userHospitalsSpecialty ClinicsAmbulatory Surgical Centers (ASCs)Distribution ChannelPublic healthcare systemsPrivate healthcare providersTechnologyMinimally invasive techniquesRobotic-assisted surgeryTraditional open surgeryPatient DemographicsAgeSocioeconomic statusGeographyNorth AmericaUSCanadaEuropeGermanySpainUKAPACIndiaMalaysiaThailandSouth AmericaArgentinaBrazilRest of World (ROW)

By Type Insights

The male to female segment is estimated to witness significant growth during the forecast period.The market encompasses various procedures aimed at helping individuals with gender dysphoria transition into their identified gender. This process often includes hormone therapy and psychological counseling to ensure readiness and understanding of the implications. Hormone therapy, while not mandatory, helps patients align their physical appearance with their gender identi

IntroductionPuberty suppression using gonadotropin-releasing hormone agonists (GnRHa) is a reversible medical intervention that halts endogenous puberty, allowing transgender and gender-diverse (TGD) adolescents to avoid the development of secondary sexual characteristics that may cause psychological distress. This pause in pubertal progression provides time to explore gender identity or facilitates alignment with affirmed gender in those with an established identity. While widely used, long-term evidence on the efficacy and safety of GnRHa in this population remains limited. This systematic review aims to synthesize current data on the benefits and potential risks of GnRHa in TGD adolescents.MethodsWe conducted a comprehensive literature search across PubMed, EMBASE, Cochrane Library, and other databases, covering studies published from February 2011 to February 2024. Eligible studies included adolescents under 18 with gender dysphoria or incongruence treated with GnRHa, reporting outcomes related to efficacy or side effects. Fifty-one studies met inclusion criteria, and data on physical health, mental health, bone density, fertility, and adverse events were extracted and assessed using the GRADE approach.ResultsOf the 51 studies, 22 were rated as moderate to high-quality evidence. GnRHa effectively suppressed puberty and secondary sex characteristics. Effects on growth and body composition varied; bone mineral density declined during treatment, particularly in AMAB individuals. Mental health improved significantly, including reduced depression, anxiety, and suicidality—especially when GnRHa was followed by gender-affirming hormone therapy (GAHT). Quality of life improved over time, while body dissatisfaction often persisted during suppression and improved after GAHT or surgery. No moderate- or high-quality evidence was found on fertility, sexual function, or cancer risk.ConclusionGnRHa is effective in halting puberty and improving mental health in TGD adolescents. However, key clinical and ethical considerations—such as bone health monitoring, fertility counseling, psychological support, and informed decision-making—must guide treatment. Long-term safety remains uncertain, particularly regarding skeletal health, reproductive outcomes and cancer risk. A precision medicine approach and co-produced longitudinal studies are essential to support safe, individualized care.Systematic review registrationhttps://www.crd.york.ac.uk, identifier CRD42024528334.

Sex Reassignment Surgery Market Outlook

The global sex reassignment surgery market size was valued at approximately USD 294 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2032, reaching an estimated market size of USD 702 million by 2032. This significant growth trajectory is largely driven by increasing societal acceptance of transgender individuals, advancements in surgical techniques, and greater awareness and accessibility of gender affirmation services. The need for inclusive healthcare services tailored to the transgender community continues to bolster the market's expansion worldwide.

Societal shift towards greater acceptance and support for LGBTQ+ communities is a key growth factor in the sex reassignment surgery market. This shift is not only influencing individual and familial attitudes but also prompting legislative changes in many countries, leading to improved healthcare rights and accessibility for transgender individuals. This inclusivity fosters a supportive environment where individuals feel more empowered to pursue gender-affirming surgeries. Furthermore, growing visibility of transgender individuals in media and public life has played a critical role in normalizing transgender issues and reducing stigma, thereby increasing the demand for such surgeries.

Technological advancements in surgical procedures have significantly contributed to the growth of the sex reassignment surgery market. Innovations in surgical techniques and postoperative care are not only enhancing the safety and outcomes of these surgeries but also reducing recovery times. Surgeons are increasingly employing minimally invasive techniques that offer better aesthetic results and lower complication rates. Additionally, the integration of advanced imaging technologies and robotics in surgical procedures is further improving precision and outcomes, making the surgeries more appealing to potential candidates. These advancements are pivotal in expanding the market as they offer new possibilities for individuals seeking gender affirmation.

Accessibility and affordability of sex reassignment surgeries have improved markedly, contributing to market growth. Many countries are now offering coverage for gender-affirming surgeries under public health systems or private insurance plans, making them financially accessible to a broader population. This shift is critical in regions where high costs have previously been a barrier to accessing such surgeries. The growing number of specialized clinics and trained healthcare professionals has resulted in shorter waiting times and increased patient confidence, further driving the demand for these procedures. The rise in medical tourism for affordable and quality procedures in countries like Thailand and Mexico also propels market growth.

From a regional perspective, North America and Europe remain at the forefront of the sex reassignment surgery market owing to progressive legal frameworks and high healthcare standards. However, Asia Pacific is emerging as a significant market, driven by increasing acceptance and the availability of cost-effective surgical options. Countries like Thailand and India are becoming popular destinations for medical tourism, attracting international patients seeking quality surgeries at competitive prices. The Middle East and Africa, although slower in market development, are witnessing gradual improvements as cultural perceptions evolve and healthcare systems become more inclusive. Latin America also shows potential growth as policies and societal attitudes towards transgender individuals continue to progress.

Procedure Type Analysis

The procedure type segment of the sex reassignment surgery market is primarily divided into male-to-female (MTF) and female-to-male (FTM) surgeries. MTF surgeries are more prevalent due to a higher prevalence of individuals assigned male at birth seeking to transition to female. These procedures typically involve a combination of surgeries such as breast augmentation, facial feminization, and genital reconstruction. The advancements in surgical techniques have made these procedures safer and more effective, contributing to their increasing popularity. The demand for MTF surgeries is also driven by improved societal acceptance and the desire for individuals to align their physical appearance with their gender identity.

On the other hand, FTM surgeries are gaining prominence with advancements in surgical methods that enhance outcomes. These procedures often involve mastectomy, phalloplasty, or metoidioplasty, each offering unique benef

The global neovaginal surgery market was valued at USD 2.4 billion in 2025 and is projected to reach USD 5.7 billion by 2033, exhibiting a CAGR of 8.98% during the forecast period. Rising prevalence of transgender surgeries, growing awareness about gender dysphoria, and increasing demand for cosmetic procedures, primarily driven by social media influence, are the primary factors fueling market growth. Transgender surgeries accounted for the largest share of the neovaginal surgery market in 2025. Vaginoplasty, in particular, is gaining traction due to advancements in surgical techniques and improved surgical outcomes. Reconstructive surgeries are also expected to witness significant growth due to the increasing incidence of childbirth injuries, trauma, and congenital abnormalities. The growing patient pool, particularly in emerging economies, and the expansion of healthcare facilities in these regions will further drive market expansion. Recent developments include: , Recent developments in the Neovaginal Surgery Market have showcased notable growth dynamics as several prominent players, such as B. Braun Melsungen, Smith and Nephew, and Medtronic, are increasingly investing in innovative surgical technologies. Investment in R&D for advanced minimally invasive surgical options has gained traction, thereby enhancing patient outcomes and operational efficiencies. Current affairs highlight the emphasis on regulatory compliance and safety standards as companies like Hologic and Olympus Corporation are leading discussions around best practices associated with neovaginal procedures. Additionally, the market has seen significant merger and acquisition activities. Notably, major players such as Abbott Laboratories and Boston Scientific have pursued strategic partnerships to broaden their product portfolios, resulting in improved market positioning and expanded access to advanced surgical solutions. The collaboration between Intuitive Surgical and other market leaders is anticipated to drive advancements in robotic surgical systems, positioning them favorably in an increasingly competitive landscape. The overall market valuation for neovaginal surgery has surged, reflecting heightened interest and investment, which is expected to facilitate new innovation and expand treatment options for patients, thereby improving overall healthcare delivery., Neovaginal Surgery Market Segmentation Insights. Key drivers for this market are: Growing transgender population needs, Increased awareness and acceptance; Advancements in surgical techniques; Rising investment in healthcare; Expansion of support services and networks. Potential restraints include: Rising transgender population, Advancements in surgical techniques; Increased awareness and acceptance; Growing healthcare expenditure; Supportive regulatory environment.

Testosterone Replacement Therapy Market Outlook

The global Testosterone Replacement Therapy (TRT) market size was valued at approximately USD 2.5 billion in 2023 and is projected to reach around USD 4.0 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.4% from 2024 to 2032. This significant growth is driven by an increasing awareness of men's health issues, rising incidences of testosterone deficiency, and the growing acceptance of hormone therapy treatments. Factors such as aging populations, improved healthcare access, and advancements in treatment options are fostering market expansion. The growing focus on personalized medicine and the continuous introduction of innovative delivery systems are also expected to fuel market growth over the forecast period.

One of the primary factors contributing to the growth of the Testosterone Replacement Therapy market is the increasing prevalence of hypogonadism, a condition characterized by low testosterone levels. As the global population ages, the incidence of testosterone deficiency-related conditions is on the rise, prompting more individuals to seek treatment. This demographic shift is bolstering the demand for TRT products, as older adults are more prone to experiencing symptoms associated with low testosterone, such as decreased energy levels, reduced muscle mass, and diminished sexual function. Additionally, heightened awareness and diagnosis of testosterone deficiency have led to more individuals seeking medical consultations, thus driving the overall market demand for therapeutic options.

Moreover, the cultural shift towards greater acceptance of hormone therapies for gender dysphoria is contributing to market growth. As societal understanding of gender identity evolves, there is increasing recognition and acceptance of gender-affirming treatments, including testosterone therapy for transgender individuals. This growing acceptance is supported by improved healthcare policies and practices that ensure access to these essential therapies. As a result, the demand for TRT among transgender individuals has been steadily increasing, encouraging manufacturers to develop more inclusive and patient-friendly products. This expansion in application areas not only diversifies the market but also opens up new opportunities for innovation and growth.

Technological advancements in drug delivery systems are further propelling the market forward. Innovations such as long-acting injections, transdermal gels, and patches are providing patients with more convenient and less invasive treatment options. These advancements in drug formulations and delivery methods enhance patient compliance, which is critical for the long-term success of testosterone therapy. Additionally, research and development efforts are focusing on creating more effective and patient-centric products, which is expected to result in an increase in the adoption of TRT solutions. The integration of digital health technologies for monitoring treatment efficacy and patient adherence is also anticipated to enhance market growth.

The regional outlook for the Testosterone Replacement Therapy market indicates significant variability in growth patterns across different geographies. North America is currently the largest market, driven by high healthcare spending, increased awareness of testosterone-related conditions, and a proactive approach towards men's health issues. Europe follows closely, benefiting from well-established healthcare systems and rising acceptance of gender-affirming therapies. The Asia Pacific region is expected to witness the fastest growth over the forecast period, supported by increasing healthcare expenditures, growing awareness of testosterone deficiency, and improving access to healthcare services. In contrast, the markets in Latin America and the Middle East & Africa are anticipated to grow at a moderate pace, influenced by varying degrees of healthcare infrastructure development and cultural acceptance of hormone therapies.

Product Type Analysis

The Testosterone Replacement Therapy market is segmented based on product types, including gels, injections, patches, implants, and others. Gels are currently among the most popular forms of testosterone replacement therapy, favored for their ease of use and ability to provide consistent testosterone levels when applied daily. Their non-invasive nature makes them particularly appealing to patients who are averse to needles or surgical procedures. These gels are formulated to be absorbed through the skin, offering a convenient and effective means of administering testosterone. However, considerations such as pot

As of February 10, 2025, 37 percent of transgender adolescents aged 13 to 17 years in the United States were living in a state that banned best practice medication and surgical care for transgender youth, while three percent were living in a state that bans best-practice surgical care. Such legislation typically aims to restrict access to gender-affirming medical care for transgender people under 18, despite evidence to show that medical care bans increase the risk of harm for trans youth when they are forced to find care elsewhere. Laws targeting transgender students Recently, there has been a rise in state legislation restricting LGBTQ+ youth in the United States, particularly in K-12 schools. A growing number of transgender students have been banned from playing on school sports teams corresponding to their gender identity, and restricted from accessing their preferred bathrooms or locker rooms. Additionally, there has been an increase in laws that explicitly require teachers and staff to tell parents that their child is transgender, despite the risk of students facing harm from potentially unsupportive families.

Important notice

The Office for Statistics Regulation confirmed on 12/09/2024 that the gender identity estimates from Census 2021 are no longer accredited official statistics and are classified as official statistics in development.

For further information please see: Sexual orientation and gender identity quality information for Census 2021

These datasets provide Census 2021 estimates that classify usual residents aged 16 years and over in England and Wales for gender identity by sex, gender identity by age and gender identity by sex and age.

Gender identity

Gender identity refers to a person's sense of their own gender, whether male, female or another category such as non-binary. This may or may not be the same as their sex registered at birth.

Non-binary

Someone who is non-binary does not identify with the binary categories of man and woman. In these results the category includes people who identified with the specific term "non-binary" or variants thereon. However, those who used other terms to describe an identity that was neither specifically man nor woman have been classed in "All other gender identities".

Sex

This is the sex recorded by the person completing the census. The options were "Female" and "Male".

Trans

An umbrella term used to refer to people whose gender identity is different from their sex registered at birth. This includes people who identify as a trans man, trans woman, non-binary or with another minority gender identity.

Trans man

A trans man is someone who was registered female at birth, but now identifies as a man.

Trans woman

A trans woman is someone who was registered male at birth, but now identifies as a woman.

Usual resident

A usual resident is anyone who on Census Day, 21 March 2021, was in the UK and had stayed or intended to stay in the UK for a period of 12 months or more, or had a permanent UK address and was outside the UK and intended to be outside the UK for less than 12 months.

Notes:

• To ensure that individuals cannot be identified in the data, population counts have been rounded to the nearest five and counts under 10 have been suppressed.

• Percentages have been calculated using rounded data.

The global market for LGBTQ+ dating apps is experiencing robust growth, driven by increasing smartphone penetration, greater social acceptance of LGBTQ+ identities, and the inherent limitations of traditional dating methods for this community. The market, estimated at $2 billion in 2025, is projected to experience a Compound Annual Growth Rate (CAGR) of 15% from 2025 to 2033, reaching an estimated $6 billion by 2033. This growth is fueled by diverse user needs, leading to the rise of niche apps catering to specific identities (lesbian, gay, bisexual, transgender) and preferences (casual dating, long-term relationships). Furthermore, innovative features like advanced matching algorithms, video chat integration, and safety measures are enhancing user engagement and attracting a broader audience. The market is segmented geographically, with North America and Europe currently holding the largest market share, but rapid growth is expected in Asia-Pacific and other emerging markets as social norms evolve and technology accessibility increases. Competition is fierce, with established players like Grindr, Tinder, and Bumble vying for market share alongside numerous niche apps tailored to specific LGBTQ+ communities. The continued evolution of mobile technology and social attitudes will significantly impact future market growth. The major restraints include concerns over data privacy and security, the potential for scams and harassment within the apps, and the ongoing challenge of effectively moderating content to ensure a safe and inclusive environment for all users. Regulation and legal frameworks concerning online dating and user data protection are also evolving, impacting app development and operation. The competitive landscape is characterized by both established players and emerging niche players constantly innovating to attract and retain users. Cloud-based solutions are gaining traction due to their scalability and cost-effectiveness compared to on-premises solutions. Future growth will depend heavily on addressing user concerns about safety and privacy, adapting to changing social norms, and leveraging technological advancements to personalize user experience and improve matching accuracy. Strategies focusing on inclusivity and community building will be crucial for long-term success in this dynamic market.

Footnotes:1The boundaries and names of census geographies can change from one census to the next. In order to facilitate data comparisons between censuses, previous census data have been adjusted to reflect as closely as possible the 2021 boundaries of these areas. The methodology used for this adjustment involved spatially linking blocks of previous censuses (concordance to the 1996 Census used the 1996 enumeration areas to the 2021 boundaries). A previous census block was linked to the 2021 area within which its representative point fell. A limited number of interactive linkages were completed to further enhance the adjustment in certain areas. For some census geographies, it was not possible to reflect the 2021 boundaries. The 2021 boundaries may not be reflected as there was no previous census block to assign to the 2021 area. As well previous census data for some 2021 areas may not be available due to the fact that the concordance did not produce an accurate representation of the 2021 area.2Gender refers to an individual's personal and social identity as a man, woman or non-binary person (a person who is not exclusively a man or a woman). Gender includes the following concepts: gender identity, which refers to the gender that a person feels internally and individually; gender expression, which refers to the way a person presents their gender, regardless of their gender identity, through body language, aesthetic choices or accessories (e.g., clothes, hairstyle and makeup), which may have traditionally been associated with a specific gender. A person's gender may differ from their sex at birth, and from what is indicated on their current identification or legal documents such as their birth certificate, passport or driver's licence. A person's gender may change over time. Some people may not identify with a specific gender. Sex 'Sex' refers to whether the person is male or female.3Given that the non-binary population is small, data aggregation to a two-category gender variable is sometimes necessary to protect the confidentiality of responses provided. In these cases, individuals in the category “non-binary persons” are distributed into the other two gender categories and are denoted by the “+” symbol. The sex variable in census years prior to 2021 and the two-category gender variable in the 2021 Census are included together in the [data table]. Although sex and gender refer to two different concepts, the introduction of gender is not expected to have a significant impact on data analysis and historical comparability, given the small size of the transgender and non-binary populations. For additional information on changes of concepts over time, please consult the Age, Sex at Birth and Gender Reference Guide.4Prior to the 2021 Census, this category refers to males. Starting in 2021, this category includes men (and/or boys), as well as some non-binary persons.5Low-income status refers to the income situation of the statistical unit in relation to a specific low-income line in a reference year. Statistical units with income that is below the low-income line are considered to be in low income. For the 2021 Census, the reference period for low-income data is the calendar year 2020.6Age' refers to the age of a person (or subject) of interest at last birthday (or relative to a specified, well-defined reference date).7Low-income status refers to the income situation of the statistical unit in relation to a specific low-income line in a reference year. Statistical units with income that is below the low-income line are considered to be in low income. For the 2021 Census, the reference period for low income data is the calendar year 2020.8Prevalence of low income - The proportion or percentage of units whose income falls below a specified low-income line.

Transgender people, often referred to as the Hijras in the Indian subcontinent, are an officially recognized third gender in the country and consider themselves neither male nor female. As per the latest census in 2011, India recorded over 487 thousand people who identified as the third gender, most of whom came from the northern state of Uttar Pradesh.

Socioeconomics of Hijras 

Hijras are associated by several terms, depending on culture and linguistics. In various Indian languages, Hijras are called Napunsakudu (Telugu), Thiru Nangai (Tamil), Khwaja Sara (Urdu), Khusra (Punjabi) and Mangalamukhi (Kannada) among others. The third gender is inherent to Indian mythology.

Socio-economically, Hijras live in well-defined communities, led by a Guru or teacher. They consist of generations of the third gender who were rejected by or fled from their birth-families. Apart from sex-work, performing at auspicious social gatherings or plain extortion was how most survived. This was due to the lack of education and employment due to their low status in their society’s hierarchy. This also meant that they underwent brutal violence with little or no opportunity for justice.

 Indian law and the third gender  

When the country’s Supreme Court re-criminalized homosexuality in 2013, there was a sharp increase in violence against the third gender by the Indian Police Service, far from investigating reports of sexual assault. Later in 2014, with the support of activists and NGOs lobbying for human rights, the same highest court ruled the recognition of the third gender community, equal to the socially and economically backward class. This meant that they now had access to proportional representation in education and jobs.

Testosterone Hormone Drug Market Outlook

The global testosterone hormone drug market size in 2023 is estimated at USD 3.1 billion, with a projected market size of USD 4.7 billion by 2032, growing at a CAGR of 4.7%. The steady growth of the market is primarily driven by increasing awareness and diagnosis of conditions like hypogonadism and gender dysphoria, coupled with advancements in testosterone replacement therapies.

The escalating prevalence of hypogonadism is one of the foremost growth factors propelling the testosterone hormone drug market. Hypogonadism, characterized by the body's inadequate production of testosterone, affects a significant proportion of the aging male population. With the rise in the elderly demographic, especially in developed regions, there is a corresponding increase in the demand for testosterone therapy. This is further accentuated by improved diagnostic techniques and a growing understanding of the condition among healthcare professionals and patients alike, leading to early diagnosis and intervention.

Another crucial growth driver is the growing recognition and medical treatment of gender dysphoria. As societal acceptance and awareness of transgender issues expand, more individuals are seeking medical interventions, including hormone replacement therapies, to align their physical characteristics with their gender identity. The medical community's increasing support for these treatments and expanding insurance coverage for gender-affirming therapies are significantly boosting the demand for testosterone hormone drugs.

Additionally, the continuous advancements in drug delivery systems are enhancing the market dynamics. Innovations such as long-acting injectables and more user-friendly transdermal systems are improving patient compliance and satisfaction. These developments not only make testosterone replacement therapy more accessible and convenient but also reduce the risks associated with more invasive methods, thereby broadening the market base. Furthermore, ongoing research and development activities are likely to introduce new and more effective formulations of testosterone drugs, further fueling market growth.

Regionally, North America holds the largest share of the testosterone hormone drug market. This dominance can be attributed to the high prevalence of hypogonadism, increased healthcare spending, and robust healthcare infrastructure. The region also benefits from a higher rate of awareness and diagnosis, coupled with favorable insurance coverage policies. Europe follows closely, driven by similar factors, and the Asia Pacific region is expected to witness the highest growth rate due to increasing healthcare access and growing awareness of testosterone-related conditions.

Product Type Analysis

The testosterone hormone drug market is segmented into various product types, including injectable, oral, transdermal, and others. Injectable testosterone drugs have been the most traditional and widely used form of testosterone replacement therapy. Their popularity stems from their efficacy and relatively quick onset of action. Despite the need for periodic injections, which can be a deterrent for some patients, injectables continue to hold a significant market share due to their proven effectiveness in treating conditions like hypogonadism. However, advancements in long-acting formulations are addressing the compliance issues associated with frequent injections.

Oral testosterone drugs represent another significant segment. These are preferred by patients who are averse to needles and looking for a more convenient method of administration. While oral testosterone has faced challenges related to its bioavailability and potential liver toxicity, recent advancements in formulation technology are enhancing its safety profile and efficacy. This segment is poised for growth as ongoing research continues to address these historical limitations, making oral testosterone a more viable option for a larger patient base.

Transdermal testosterone drugs, including patches and gels, have gained substantial traction in recent years. These products offer a non-invasive and more consistent delivery of testosterone, improving patient adherence to therapy. The convenience of daily application and the ability to maintain stable testosterone levels are significant advantages driving the adoption of transdermal systems. Innovations in this segment, such as improved patch adhesion and more efficient gel formulations, are likely to spur further growth.

Other forms o